Literature DB >> 33210486

[Morbidity of congenital heart disease in children with anorectal malformations and related treatment].

Yun Liu1, Kaikai Li1, Juan Wu1, Hezhou Li1, Xiaoduan Geng1, Yachuan Gu2.   

Abstract

OBJECTIVE: To investigate the morbidity of congenital heart defects(CHDs) in children with anorectal malformation, and to summarize appropriate treatment.
METHODS: The clinical data and echocardiographic findings of 155 children with congenital anorectal malformations from the Third Affiliated Hospital of Zhengzhou University during January 2016 and October 2019 were reviewed. According to the surgical findings of anorectal malformations, the patients were categorized as the high/intermediate group and the low group; the CHDs were classified as minor CHDs and major CHDs. Multiple logistic regression was used to analyze the correlation of wingspread classification, and extracardiac malformations with the severity of CHDs.
RESULTS: Out of 155 children with anorectal malformations, 47 (30.3%) had different types of cardiac structural malformations, including 18 cases of minor CHDs (11.6%) and 29 cases of major CHDs (18.7%). Sixty children (38.7%) had extracardiac malformations, of which 38 cases (24.5%) had a single extracardiac malformation, 15 cases (9.7%) had multiple extracardiac malformations, 6 had trisomy 21 syndrome, and 1 had VATER syndrome. Multivariate logistic regression analysis showed that wingspread classification of anorectal malformation and extracardiac disorders were independent risk factors for major CHDs. The probability of major CHDs in children with high/intermediate anorectal malformation was 4.709 times higher than that with low anorectal malformation (OR=4.709, 95% CI: 1.651-13.432, P<0.01). The probability of major CHDs was 3.85 times higher for increasing each additional grade of extracardiac malformations(without, with single, or multiple malformations) (OR=3.850, 95% CI: 2.065-7.175, P<0.01). According to the presence and severity of CHDs, children with anorectal malformations were classified into three categories: without CHDs, with minor CHDs and with major CHDs, for differential treatment and management. Anorectal malformations would be treated and managed in children without CHDs and with minor CHDs following the original plan; however, children with minor CHDs may require cardiac follow-up after surgery. In children with major CHDs, the personalization tactics were developed based on the principle of emergency first. There were increased perioperative infection rate (P<0.05), longer hospital days (P<0.01), reduced cure rate (P<0.05) and increased mortality (P<0.05) in children with major, compared with those without CHDs and minor CHDs.
CONCLUSIONS: The morbidity of major CHDs is higher in severe cases with high/intermediate anorectal malformation and acute cases without fistula or with obstructed fistula and cases with multiple congenital disorders. Echocardiography can define the type and severity of CHDs, which are useful to develop the optimal diagnosis and treatment plan for children with anorectal malformation.

Entities:  

Keywords:  Congenital ano-rectal malformation; Congenital heart disease; Extracardiac malformations; Retrospective analysis; Therapy; Urogenital abnormalities; Wingspread classification

Mesh:

Year:  2020        PMID: 33210486      PMCID: PMC8800670          DOI: 10.3785/j.issn.1008-9292.2020.10.08

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  10 in total

1.  Congenital cardiac anomalies and imperforate anus: A hospital's experience.

Authors:  Jamal S Kamal; Ahmad S Azhar
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

2.  Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography.

Authors:  Wyman W Lai; Tal Geva; Girish S Shirali; Peter C Frommelt; Richard A Humes; Michael M Brook; Ricardo H Pignatelli; Jack Rychik
Journal:  J Am Soc Echocardiogr       Date:  2006-12       Impact factor: 5.251

3.  Outcome of primary posterior sagittal anorectoplasty of high anorectal malformation in well selected neonates.

Authors:  O D Osifo; T O Osagie; E O Udefiagbon
Journal:  Niger J Clin Pract       Date:  2014 Jan-Feb       Impact factor: 0.968

4.  Anorectal malformations, associated congenital anomalies and their investigation in a South African setting.

Authors:  Elmarie Vd Merwe; S Cox; A Numanoglu
Journal:  Pediatr Surg Int       Date:  2017-06-13       Impact factor: 1.827

5.  Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study.

Authors:  Qu-ming Zhao; Xiao-jing Ma; Xiao-ling Ge; Fang Liu; Wei-li Yan; Lin Wu; Ming Ye; Xue-cun Liang; Jing Zhang; Yan Gao; Bing Jia; Guo-ying Huang
Journal:  Lancet       Date:  2014-04-22       Impact factor: 79.321

6.  Is routine preoperative 2-dimensional echocardiography necessary for infants with esophageal atresia, omphalocele, or anorectal malformations?

Authors:  Ahmed Nasr; Patrick J McNamara; Luc Mertens; David Levin; Andrew James; Helen Holtby; Jacob C Langer
Journal:  J Pediatr Surg       Date:  2010-05       Impact factor: 2.545

7.  Prevalence of congenital heart disease in patients undergoing surgery for major gastrointestinal malformations: an Indian study.

Authors:  Rajendra K Gokhroo; Sajal Gupta; Garima Arora; Devendra S Bisht; Deepak Padmanabhan; Varsha Soni
Journal:  Heart Asia       Date:  2015-06-05

8.  Cardiovascular anomalies with imperforate anus.

Authors:  O H Teixeira; K Malhotra; J Sellers; S Mercer
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

Review 9.  Anorectal malformations.

Authors:  Richard S Herman; Daniel H Teitelbaum
Journal:  Clin Perinatol       Date:  2012-06       Impact factor: 3.430

10.  Congenital Anorectal Malformation Severity Does Not Predict Severity of Congenital Heart Defects.

Authors:  Jara E Jonker; Eryn T Liem; Nynke J Elzenga; Bouwe Molenbuur; Monika Trzpis; Paul M A Broens
Journal:  J Pediatr       Date:  2016-09-26       Impact factor: 4.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.